Cogwheel rigidity in Parkinson's disease: Clinical, biomechanical and neurophysiological features

Cogwheel rigidity in Parkinson's disease: Clinical, biomechanical and neurophysiological features

Objectives: Cogwheel rigidity in Parkinson's disease has been poorly investigated so far, thus leaving the scientific interpretation of this phenomenon substantially unsolved. A detailed clinical, biomechanical and neurophysiological investigation would clarify the pathophysiological underpinni...

Full description

Saved in:

Bibliographic Details
Main Authors:	Marco Falletti, Francesco Asci, Alessandro Zampogna, Martina Patera, Antonio Suppa
Format:	Article
Language:	English
Published:	Elsevier 2025-08-01
Series:	Neurobiology of Disease
Subjects:	Pathophysiology Parkinson's disease Rigidity Levodopa (L-dopa) Bioomechanical measures Neurophysiological measures
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996125001962
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Abnormal arm swing movements in Parkinson’s disease: onset, progression and response to L-Dopa
by: M. Patera, et al.
Published: (2025-03-01)

Pain in Parkinson's disease Dor na doença de Parkinson
by: Grace Helena Letro, et al.
Published: (2009-09-01)

Discinesias induzidas por levodopa em 176 pacientes com doença de Parkinson Levodopa-induced dyskinesias in 176 parkisonian patients
by: Maria Sheila G. Rocha, et al.
Published: (1995-12-01)

How I treat Parkinson's disease
by: Egberto Reis Barbosa, et al.
Published: (2022-08-01)

Hyponatremia in Parkinson’s Disease: The Impact of Carbidopa-Levodopa Therapy
by: Elizabeth Schumacher, et al.
Published: (2025-06-01)

Clinical and brain functional correlates of instrumental rigidity measurement in Parkinson’s disease
by: Yoshikazu Nakano, et al.
Published: (2025-03-01)

Parkinson&rsquo;s disease managing reversible neurodegeneration
by: Hinz M, et al.
Published: (2016-04-01)

A novel missense mutation pattern of the GCH1 gene in dopa-responsive dystonia Novo padrão de mutação missense no gene GCH1 na distonia dopa-responsiva
by: Rosana H. Scola, et al.
Published: (2007-12-01)

Contribution of dopaminergic polymorphisms to levodopa treatment response and drug concentration in Chinese patients with Parkinson’s disease
by: Xiaoqin He, et al.
Published: (2025-01-01)

Análise acústica da prosódia em mulheres com doença de Parkinson: efeito da Levodopa Acoustic analysis of prosody in females with Parkinson's disease: effect of L-dopa
by: Luciana L. Azevedo, et al.
Published: (2003-12-01)

Longitudinal analysis of pupillometry according to type of pharmacotherapy in Parkinson’s disease patients
by: Olga Bartošová, et al.
Published: (2025-08-01)

Bereitschaftspotential preceding eyelid blinks in Parkinson’s disease
by: Isabella Araújo Mota, et al.

Low serum uric acid levels and levodopa-induced dyskinesia in Parkinson's disease
by: Nayron Medeiros Soares, et al.
Published: (2023-01-01)

Effect of levodopa on interleukin-15 and RANTES circulating levels in patients affected by Parkinson's disease
by: Sebastiano Gangemi, et al.
Published: (2003-01-01)

Tratamento da doença de Parkinson
by: Francisco Cardoso
Published: (1995-03-01)

Identification of electromyographic patterns of bradykinesia in patients with Parkinson's disease
by: Nikita Kozulin, et al.
Published: (2024-10-01)

Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
by: Bruno Lopes SANTOS-LOBATO, et al.
Published: (2020-04-01)

Prosody and levodopa in Parkinsons disease
by: Luciana Lemos de Azevedo, et al.
Published: (2013-11-01)

Technological Advances for Gait and Balance in Normal Pressure Hydrocephalus: A Systematic Review
by: Alessandro Zampogna, et al.
Published: (2025-01-01)

Specificity and sensibility of 9-Itens Wearing-off Questionnaire in Brazilian Parkinson disease patient sample
by: Jasper Guimarães Santos, et al.
Published: (2014-11-01)

Retinal Thickness in Patients with Parkinson’s Disease and Dopa Responsive Dystonia—Is There Any Difference?
by: Marko Svetel, et al.
Published: (2025-05-01)

Working memory in Parkinson's disease patients: clinical features and response to levodopa Memória de trabalho em pacientes com doença de Parkinson: características clínicas e resposta a levodopa
by: Rogério Beato, et al.
Published: (2008-06-01)

Quality of life scale in parkinson's disease PDQ-39 - (Brazilian Portuguese version) to assess patients with and without levodopa motor fluctuation Escala para qualidade de vida na doença de Parkinson - PDQ 39 (versão do Português falado no Brasil) como instrumento para avaliação de pacientes com e sem flutuação motora decorrente da levodopa
by: Renata Guzzo Souza, et al.
Published: (2007-09-01)

Levodopa-induced motor complications associated with benserazide and carbidopa in Parkinson’s disease: a disproportionality analysis of the FAERS database
by: Huaide Qiu, et al.
Published: (2025-03-01)

Respiratory changes in Parkinson's disease may be unrelated to dopaminergic dysfunction
by: Luciana Ulhôa Guedes, et al.
Published: (2012-11-01)

Symptom improvement in a South Asian patient with Parkinson’s disease treated with immediate- and extended-release carbidopa–levodopa: a case report
by: Gail Reiner, et al.
Published: (2025-07-01)

Efficacy and motor complications of original and generic levodopa in Parkinson&#39;s disease treatment
by: Kasemsap N, et al.
Published: (2016-05-01)

A comprehensive review of deep brain stimulation for Parkinson's disease: The history, current state of the art and future possibilities
by: Avery Foote, et al.
Published: (2025-06-01)

DOPAMINE DYSREGULATION SYNDROME IN PARKINSON’S DISEASE AND APPROACHES TO ITS CORRECTION WITH DRUGS
by: S. M. Omarova, et al.
Published: (2017-07-01)

Hemodynamic subtype profiling in tremor-dominant and akinetic–rigid Parkinson’s disease using multi-delay pseudo-continuous arterial spin labeling imaging
by: Yu Pan, et al.
Published: (2025-07-01)

How to dose extended-release carbidopa-levodopa capsules (IPX203, CREXONT®) in patients with Parkinson’s disease
by: Robert A. Hauser, et al.
Published: (2025-01-01)

Quantitative analysis of gait parameters in Parkinson’s disease and the clinical significance
by: Wenchao Yin, et al.
Published: (2025-08-01)

Levodopa induces thyroid function regulation in a patient with thyroid hormone resistance and Parkinson’s disease: a case report
by: Gabriela Rozo-Paz, et al.
Published: (2025-03-01)

Bioequivalence of Foslevodopa/Foscarbidopa continuous subcutaneous infusion to arm, thigh, or flank versus abdomen in healthy and advanced Parkinson’s disease individuals
by: Yi Rang Han, et al.
Published: (2025-01-01)

Inefficacy of Repetitive Transcranial Magnetic Stimulation in Parkinson’s Disease Patients with Levodopa-Induced Dyskinesias: Results from a Pilot Study
by: Alma Medrano-Hernández, et al.
Published: (2025-07-01)

Experience in using levodopa-benserazide
by: Elena Anatolyevna Katunina, et al.
Published: (2015-10-01)

Novos agonistas dopaminérgicos
by: MATTOS JAMES PITÁGORAS DE, et al.
Published: (1999-01-01)

Levodopa and pramipexole combination therapy efficacy in Vietnamese patients with Parkinson’s disease: a randomized controlled trial
by: Minh Van Le, et al.
Published: (2024-03-01)

Trampoline reflex. Neurophysiological and experimental model
by: S. V. Muravyov, et al.
Published: (2025-04-01)

Complications associated with intestinal infusion therapies in patients with Parkinson’s disease: a single-center retrospective study and 15-year experience
by: Igor Straka, et al.
Published: (2025-05-01)